ORTEXORTEX News
Tracking ONC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ON

BeOne Medicines AG (ONC) short interest & options flow

NASDAQ

ONC heads into its November 5 earnings release with a notable convergence of insider selling, activist stake reduction, and a stock that has slipped nearly 2% on the week to $370.33. Short interest at BeOne is modest and not the story here. At 1.6% of the free float, around 1.79 million shares, it has nudged up roughly 22% over the past month in share terms, but from a low base…

Latest pulse2 Oct 2026

ONC short interest jumped 20.6% over the past week to 1.61% of free float, driven by director Wang Xiaodong's sustained selling activity under a 10b5-1 plan totalling over $11.3 million on 28 September.

$377.78+6.42% 1d+1.18% 1w+5.50% 1mClose: 4 Nov 2026
Short interest % of float
Low
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$42.95B
Next earnings
5 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of BeOne Medicines AG (ONC) share price and short interest (% of free float), six months to November 4, 2026

ONC news and analysis

RSS

Want the live picture for ONC?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ONC — free to start on ORTEX.

Sign up for free →Open ONC on ORTEX